Published on 3 Apr 2024 on Insider Monkey via Yahoo Finance

Chemed Corporation (CHE) Rose 13% in Q4

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. Global equity markets closed out 2023 with their highest quarterly returns this year, following a period of weakness. In the fourth quarter, the strategy returned 14.87% (gross) and 14.59% (net) compared to 14.55% for the Russell Midcap Growth Index. In addition, please check the fund’s top five holdings to know its best picks in 2023.

TimesSquare Capital Management U.S. Focus Growth Strategy featured stocks like Chemed Corporation (NYSE:CHE) in the fourth quarter 2023 investor letter. Headquartered in Cincinnati, Ohio, Chemed Corporation (NYSE:CHE) offers hospice and palliative care services. On April 2, 2024, Chemed Corporation (NYSE:CHE) stock closed at $636.82 per share. One-month return of Chemed Corporation (NYSE:CHE) was 0.09%, and its shares gained 15.84% of their value over the last 52 weeks. Chemed Corporation (NYSE:CHE) has a market capitalization of $9.627 billion.

TimesSquare Capital Management U.S. Focus Growth Strategy stated the following regarding Chemed Corporation (NYSE:CHE) in its fourth quarter 2023 investor letter: